Biomerica Inc (BMRA) income statement
BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3055% below fair value
$1.09−0.15 (-11.74%)
Close on Nov 18, 2026Market cap $5.01MP/E –Yield –
Biomerica Inc income statement
Ratios
Latest available, balances at Aug 31, 2026
Profitability, TTM
- Gross margin
- 0.9%
- Operating margin
- -125.2%
- Net margin
- -115.5%
- Return on equity, FY2026
- -112.1%
Financial strength
- Current ratio
- 1.91
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 96.3%
Valuation
- P/E ratio
- –
- Price to sales
- 1.16
- Price to book
- 1.37
- Dividend yield
- –
See a number that looks wrong?